The Ministry of Health is considering measures to decrease HIV transmission associated with injectable drug use, with a focus on the implementation of a safe syringe program. Health Minister Dr. Atonio Lalabalavu emphasized in a parliamentary session that it is crucial to explore various options without creating the impression that the ministry supports drug use.
Dr. Lalabalavu indicated that the safe syringe initiative must be framed not only as a means to reduce HIV transmission through injectables but also in terms of its potential implications on drug use advocacy. He stressed that discussions around this topic should involve not only the ministry and government but also relevant stakeholders.
While global HIV rates are declining, the situation in Fiji presents a contrasting narrative. The country is reported to have the second-highest rate of new HIV cases in the Asia-Pacific region, surpassed only by the Philippines. Dr. Lalabalavu noted that out of 552 new HIV diagnoses in the first half of 2024, 15 percent were linked to injectable drug use.
The ministry has been working to enhance access to HIV testing and treatment services throughout the nation and is promoting harm reduction strategies while combating stigma and discrimination towards those affected by HIV. Dr. Lalabalavu revealed that the Fiji National HIV Surge Strategy 2024-2027 is being finalized for submission to the Cabinet. This strategy comprises five key priority areas aimed at reducing HIV transmission and improving public health treatment, care, human rights, and social justice for individuals living with HIV.
For the fiscal year of 2024/2025, the government has allocated $200,000 for HIV/AIDS prevention and control initiatives. Dr. Lalabalavu mentioned that the ministry will explore additional funding avenues through donors and other stakeholders. Efforts are also underway to enhance accessible HIV testing at local hospitals and health centers. He concluded by explaining that the recent surge in HIV cases is primarily due to an increase in testing activities.